ZR2 Bioenergy Ltd
Incorporated in 1939, ZR2 Bioenergy Limited is in the business of Ethanol and bioenergy products.[1]
- Market Cap ₹ 217 Cr.
- Current Price ₹ 136
- High / Low ₹ 385 / 90.0
- Stock P/E 236
- Book Value ₹ 87.9
- Dividend Yield 0.00 %
- ROCE 0.70 %
- ROE 0.50 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.42% over last 3 years.
- Earnings include an other income of Rs.1.80 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | 0.00 | 1.57 | 1.49 | 0.00 | 0.00 | |
| 0.67 | 0.63 | 0.72 | 0.59 | 0.63 | 0.73 | 0.14 | 1.11 | 0.25 | 1.46 | 1.86 | 0.65 | 0.68 | |
| Operating Profit | -0.67 | -0.63 | -0.72 | -0.59 | -0.63 | -0.73 | -0.14 | 0.05 | -0.25 | 0.11 | -0.37 | -0.65 | -0.68 |
| OPM % | 4.31% | 7.01% | -24.83% | ||||||||||
| 0.36 | 4.02 | 0.35 | 0.29 | 0.26 | 0.75 | 0.23 | 0.27 | 0.29 | 0.46 | 0.62 | 1.84 | 1.80 | |
| Interest | 0.07 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.19 | 0.01 | 0.00 | 0.01 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.21 | 0.22 |
| Profit before tax | -0.46 | 3.31 | -0.46 | -0.38 | -0.46 | -0.05 | 0.09 | 0.32 | 0.03 | 0.38 | 0.20 | 0.98 | 0.89 |
| Tax % | 0.00% | 41.39% | 2.17% | 0.00% | 0.00% | 0.00% | 0.00% | -21.88% | 0.00% | 0.00% | 55.00% | 28.57% | |
| -0.46 | 1.94 | -0.46 | -0.38 | -0.46 | -0.05 | 0.09 | 0.39 | 0.04 | 0.39 | 0.08 | 0.70 | 0.92 | |
| EPS in Rs | -2.88 | 12.12 | -2.88 | -2.38 | -2.88 | -0.31 | 0.56 | 2.44 | 0.25 | 1.09 | 0.22 | 0.44 | 1.67 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 51% |
| 3 Years: | 312% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 53% |
| 3 Years: | 28% |
| 1 Year: | -62% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.36 | 0.36 | 0.36 |
| Reserves | 3.11 | 5.06 | 4.59 | 4.21 | 3.76 | 3.69 | 3.80 | 4.18 | 4.21 | 16.50 | 138.98 | 139.61 |
| 0.00 | 0.00 | 0.10 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 12.01 | 22.01 | 0.00 | 0.00 | |
| 0.15 | 0.46 | 0.10 | 0.11 | 0.09 | 0.03 | 0.10 | 0.22 | 0.05 | 0.41 | 0.14 | 1.35 | |
| Total Liabilities | 3.42 | 5.68 | 4.95 | 4.48 | 4.15 | 3.88 | 4.06 | 4.56 | 16.43 | 39.28 | 139.48 | 141.32 |
| 0.44 | 0.35 | 0.27 | 0.18 | 0.11 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.50 | 0.31 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 118.90 | 120.11 |
| Investments | 0.10 | 0.10 | 0.05 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.23 | 0.26 | 0.10 | 0.10 |
| 2.88 | 5.23 | 4.63 | 4.26 | 4.02 | 3.85 | 4.03 | 4.53 | 16.17 | 39.01 | 19.98 | 20.80 | |
| Total Assets | 3.42 | 5.68 | 4.95 | 4.48 | 4.15 | 3.88 | 4.06 | 4.56 | 16.43 | 39.28 | 139.48 | 141.32 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | 3.30 | -0.88 | -0.56 | -0.66 | -2.06 | 0.26 | 0.91 | -11.34 | -19.78 | 31.00 | -0.61 | |
| -0.03 | 0.21 | 0.33 | 0.67 | 0.51 | 2.72 | -0.56 | 0.19 | -1.66 | 2.28 | -116.69 | 0.48 | |
| -0.64 | 0.00 | 0.10 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 12.00 | 21.49 | 100.39 | -0.04 | |
| Net Cash Flow | -1.16 | 3.51 | -0.45 | 0.10 | -0.15 | 0.66 | -0.30 | 1.10 | -1.01 | 3.98 | 14.70 | -0.16 |
| Free Cash Flow | -0.50 | 3.30 | -0.88 | -0.55 | -0.66 | -1.98 | 0.25 | 0.91 | -11.34 | -19.62 | -88.43 | -1.84 |
| CFO/OP | 82% | -689% | 78% | 97% | 102% | 282% | -150% | 1,780% | 4,536% | -17,973% | -8,378% | 89% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 371.29 | 432.42 | 0.00 | |||||||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 371.29 | 432.42 | 0.00 | |||||||||
| Working Capital Days | 361.85 | -4,519.49 | 169.03 | |||||||||
| ROCE % | -11.07% | -9.66% | -8.94% | -8.46% | -10.68% | -3.29% | 2.30% | 7.71% | 0.10% | 1.27% | 0.21% | 0.70% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Permanent Employees on Rolls employees |
|
|||||||||
| Trading Revenue (Revenue from Operations) INR Lakhs |
||||||||||
| Capital Work-in-Progress (Bioenergy Build-out) INR Lakhs |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for BOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026.
- Board approved Q1 FY27 unaudited standalone and consolidated results; unqualified limited review received.
- Unaudited Financial Results For The Quarter Ended 30Th June 2026
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Crisil monitoring report for June 30, 2026 notes Rs 18.50 crore deposit deployment and revised issue proceeds Rs 122.40 crore.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Closure of Trading Window
- Trading window closed from July 1, 2026 until 48 hours after Q1 FY2027 results.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
ZR2BEL is in the business of bioenergy and the waste-to-energy economy, and produces
biofuels, hydrogen and electricity, carbon credits and other derivative products from agri waste, biomass, sugar cane, grain, corn, maize, waste and RDF.